This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lam DCL, Lam B, Wong MKY, Lu C, Au WY, Tse EWC et al. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT - a randomised double-blinded placebo-controlled study. Bone Marrow Transplant 2011; 46: 1551–1556.
Lemonnier F, Catherinot E, Neveu H, Couderc LJ, Rivaud E . Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipient. European Respiratory Society Meeting. Berlin, Germany. 6 October 2008 Abstract : E1631.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Lemonnier, F., Rivaud, E., Neveu, H. et al. Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT. Bone Marrow Transplant 47, 1374 (2012). https://doi.org/10.1038/bmt.2012.23
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2012.23